For: | He Q, Kuang AR, Guan YS, Liu YQ. Puncture injection of para-toluenesulfonamide combined with chemoembolization for advanced hepatocellular carcinoma. World J Gastroenterol 2012; 18(46): 6861-6864 [PMID: 23239926 DOI: 10.3748/wjg.v18.i46.6861] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i46/6861.htm |
Number | Citing Articles |
1 |
Jui-Ling Hsu, Wohn-Jenn Leu, Lih-Ching Hsu, Shih-Ping Liu, Nan-Shan Zhong, Jih-Hwa Guh. Para-Toluenesulfonamide Induces Anti-tumor Activity Through Akt-Dependent and -Independent mTOR/p70S6K Pathway: Roles of Lipid Raft and Cholesterol Contents. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01223
|
2 |
|
3 |
Hermann AM Mucke. Patent Highlights June–July 2019. Pharmaceutical Patent Analyst 2019; 8(6): 225 doi: 10.4155/ppa-2019-0019
|
4 |
Jui-Ling Hsu, Wohn-Jenn Leu, Nan-Shan Zhong, Jih-Hwa Guh. Autophagic Activation and Decrease of Plasma Membrane Cholesterol Contribute to Anticancer Activities in Non-Small Cell Lung Cancer. Molecules 2021; 26(19): 5967 doi: 10.3390/molecules26195967
|
5 |
Chien-Teng Lin, Chuen-Fu Lin, Jui-Te Wu, Hsiao-Pei Tsai, Shu-Ying Cheng, Huei-Jyuan Liao, Tzu-Chun Lin, Chao-Hsuan Wu, Yu-Chin Lin, Jiann-Hsiung Wang, Geng-Ruei Chang. Effects of Para-Toluenesulfonamide on Canine Melanoma Xenotransplants in a BALB/c Nude Mouse Model. Animals 2022; 12(17): 2272 doi: 10.3390/ani12172272
|
6 |
Na Liu, Jianzeng Zhang, Jiaojiao Wu, Fan Feng, Yantao Chai, Yongwu Li, Bo Liu. Targeting hepatocellular carcinoma growth and metabolism: A synergistic approach with para-toluenesulfonamide and radiofrequency ablation. iLIVER 2024; 3(3): 100111 doi: 10.1016/j.iliver.2024.100111
|
7 |
Zhe Liu, Chenyuan Liang, Zhuoyuan Zhang, Jian Pan, Hui Xia, Nanshan Zhong, Longjiang Li. Para-toluenesulfonamide induces tongue squamous cell carcinoma cell death through disturbing lysosomal stability. Anti-Cancer Drugs 2015; 26(10): 1026 doi: 10.1097/CAD.0000000000000283
|